Related Experiment Video
Updated: Aug 19, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Susceptibility of methicillin-resistant Staphylococcus aureus to lysostaphin
Abstract:
One hundred and eleven isolates of methicillin-resistant Staphylococcus aureus recovered from patients at the Olin E. Teague Veterans Center from March 1983 to April 1987 were as susceptible to lysis by lysostaphin as methicillin-susceptible S. aureus controls were.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) isolates showed susceptibility to lysostaphin lysis, similar to methicillin-susceptible S. aureus controls. This finding is important for understanding MRSA susceptibility to antimicrobial agents.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen causing hospital-acquired infections.
- Understanding the susceptibility of MRSA to various antimicrobial agents is crucial for effective treatment strategies.
Purpose of the Study:
- To evaluate the susceptibility of clinical isolates of MRSA to lysis by lysostaphin.
- To compare the lysostaphin susceptibility of MRSA with that of methicillin-susceptible Staphylococcus aureus (MSSA).
Main Methods:
- One hundred and eleven MRSA isolates were collected from patients at the Olin E. Teague Veterans Center between March 1983 and April 1987.
- Susceptibility to lysis by lysostaphin was assessed for all MRSA isolates.
- Methicillin-susceptible S. aureus (MSSA) isolates served as controls for comparison.
Main Results:
- All 111 MRSA isolates demonstrated susceptibility to lysis by lysostaphin.
- The degree of susceptibility to lysostaphin lysis in MRSA isolates was comparable to that observed in MSSA control strains.
Conclusions:
- Lysostaphin effectively lyses both methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains.
- These findings suggest that lysostaphin remains a potential therapeutic agent against MRSA infections, irrespective of methicillin resistance.
Related Concept Videos
Development of Antibiotic Resistance
Staphylococcal Skin Infections
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Clinical Significance of Antibiotic Resistance

